Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study)
Lymphoma Study Group of the Japan Clinical Oncology Group
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study)'. Together they form a unique fingerprint.